Transcranial magnetic stimulation reduces pain and analgetic use in breast cancer patients

Not Applicable

Completed

• Conditions: Pain in breast cancer patients; Signs and Symptoms

• Registration Number: ISRCTN13972712
• Lead Sponsor: Hasanuddin University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-08-01
• Study Start: 2023-03-17
• Last Update Posted: 27 March 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 40

Inclusion Criteria

1. 19–60 years old
2. Used analgesics combined with opioids for pain
3. Agreed to enrol in the study

Exclusion Criteria

1. Current chemotherapy treatment containing alkaloids vinca, taxane, platinum-based preparations
2. Electrodes implanted inside the head
3. Cochlear implants
4. History of head trauma, seizure, or syncope
5. Brain lesions
6. On drug withdrawal
7. Pregnant during the study period
8. Patient left the study
9. Insufficient blood samples for evaluating serum beta-endorphins obtained

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> Measured at baseline and after five sessions:<br> 1. Pain intensity measured using a numerical rating scale (NRS) from 0-10<br> 2. Opioid usage recorded using medical records<br> 3. Serum beta-endorphin level measured using enzyme-linked immunosorbent assay (ELISA) kit for beta-endorphin<br>

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures